glp-1 agonist indications The science on receptor agonists has outpaced the public narrative. While headlines chase the latest prescription numbers, evidence-based practice demands we hold the line: obesity is a chronic, relapsing condition; not GLP-1 Medications Clinic Near Me

Semaglutide effects on heart disease and stroke in patients with overweight or obesity (SELECT)

The intention-to-treat analysis had some concerns of bias in 36% of the studies

10.1002/iub.2046 [DOI] [PubMed] [Google Scholar] 129.Vinu , Navarro J, Herrero-Cervera A, Garca-Cubas M, Andrs-Blasco I, Martnez-Hervs S, et al

Over 2.1 years, cardiovascular events were similar between the groups (13% with GLP-1RAs versus 13.8% in DPP-4is

Mounjaro is suitable for: Overweight or obese Have type 2 diabetes or insulin resistance Struggle with frequent hunger, cravings, or portion control Weight-related concerns such as high blood pressure or high cholesterol Committed to lifestyle changes, nutrition guidance, and follow-ups with doctors Mounjaro is NOT suitable for: Mounjaro is not for everyone because it affects your digestion, blood sugar response, and especially for those with medical conditions